{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T04:34:20Z","timestamp":1795062860369,"version":"4.10.2"},"reference-count":202,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Qin Chuangyuan High-Level Innovation and Entrepreneurship Talent Recruitment Program of Shaanxi","award":["QCYRCXM-2023-073"],"award-info":[{"award-number":["QCYRCXM-2023-073"]}]},{"DOI":"10.13039\/100020593","name":"Fundamental Research Funds for the Central Universities of Beijing University of Chemical Technology","doi-asserted-by":"publisher","award":["G2022WD01010"],"award-info":[{"award-number":["G2022WD01010"]}],"id":[{"id":"10.13039\/100020593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04495-z","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T13:11:53Z","timestamp":1752671513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Harnessing mesenchymal stem\/stromal cells-based therapies for rheumatoid arthritis: mechanisms, clinical applications, and microenvironmental interactions"],"prefix":"10.1186","volume":"16","author":[{"given":"Ying-Feng","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2443-6485","authenticated-orcid":false,"given":"Cheng-Hu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"issue":"12","key":"4495_CR1","first-page":"1194","volume":"327","author":"MH Smith","year":"2022","unstructured":"Smith MH, Berman JR. What Is Rheumatoid Arthritis? JAMA. 2022;327(12):1194.","journal-title":"What Is Rheumatoid Arthritis? JAMA"},{"issue":"10416","key":"4495_CR2","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","volume":"402","author":"A Di Matteo","year":"2023","unstructured":"Di Matteo A, Bathon JM, Emery P. Rheumatoid arthritis. Lancet (London England). 2023;402(10416):2019\u201333.","journal-title":"Lancet (London England)"},{"issue":"6","key":"4495_CR3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1056\/NEJMra2103726","volume":"388","author":"EM Gravallese","year":"2023","unstructured":"Gravallese EM, Firestein GS. Rheumatoid Arthritis - Common origins, divergent mechanisms. N Engl J Med. 2023;388(6):529\u201342.","journal-title":"N Engl J Med"},{"issue":"9","key":"4495_CR4","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, et al. 2010 rheumatoid arthritis classification criteria: an American college of rheumatology\/european league against rheumatism collaborative initiative. Ann Rheum Dis. 2010;69(9):1580\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4495_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315\u201324.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"4495_CR6","first-page":"591","volume":"18","author":"A Finckh","year":"2022","unstructured":"Finckh A, et al. Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol. 2022;18(10):591\u2013602.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"4495_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41392-023-01331-9","volume":"8","author":"Q Ding","year":"2023","unstructured":"Ding Q, et al. Signaling pathways in rheumatoid arthritis: implications for targeted therapy. Signal Transduct Target Therapy. 2023;8(1):68.","journal-title":"Signal Transduct Target Therapy"},{"issue":"6","key":"4495_CR8","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.smim.2009.04.002","volume":"21","author":"Y Li","year":"2009","unstructured":"Li Y, Begovich AB. Unraveling the genetics of complex diseases: susceptibility genes for rheumatoid arthritis and psoriasis. Semin Immunol. 2009;21(6):318\u201327.","journal-title":"Semin Immunol"},{"key":"4495_CR9","doi-asserted-by":"publisher","first-page":"102400","DOI":"10.1016\/j.jaut.2019.102400","volume":"110","author":"HU Scherer","year":"2020","unstructured":"Scherer HU, H\u00e4upl T, Burmester GR. The etiology of rheumatoid arthritis. J Autoimmun. 2020;110:102400.","journal-title":"J Autoimmun"},{"issue":"6","key":"4495_CR10","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1086\/498651","volume":"77","author":"RM Plenge","year":"2005","unstructured":"Plenge RM, et al. Replication of putative candidate-gene associations with rheumatoid arthritis in >\u20094,000 samples from North America and sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet. 2005;77(6):1044\u201360.","journal-title":"Am J Hum Genet"},{"key":"4495_CR11","doi-asserted-by":"crossref","unstructured":"Wysocki T, Olesi\u0144ska M, Paradowska-Gorycka A. Current Understanding of an emerging role of HLA-DRB1 gene in rheumatoid Arthritis-From research to clinical practice. Cells, 2020. 9(5).","DOI":"10.3390\/cells9051127"},{"issue":"9","key":"4495_CR12","doi-asserted-by":"publisher","first-page":"e3204","DOI":"10.1002\/jgm.3204","volume":"22","author":"M Abbasifard","year":"2020","unstructured":"Abbasifard M, Imani D, Bagheri-Hosseinabadi Z. PTPN22 gene polymorphism and susceptibility to rheumatoid arthritis (RA): updated systematic review and meta-analysis. J Gene Med. 2020;22(9):e3204.","journal-title":"J Gene Med"},{"key":"4495_CR13","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3389\/fgene.2019.00570","volume":"10","author":"MV Nemtsova","year":"2019","unstructured":"Nemtsova MV, et al. Epigenetic changes in the pathogenesis of rheumatoid arthritis. Front Genet. 2019;10:570.","journal-title":"Front Genet"},{"issue":"10","key":"4495_CR14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrrheum.2012.134","volume":"8","author":"WP Arend","year":"2012","unstructured":"Arend WP, Firestein GS. Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis. Nat Rev Rheumatol. 2012;8(10):573\u201386.","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"4495_CR15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nri2094","volume":"7","author":"IB McInnes","year":"2007","unstructured":"McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007;7(6):429\u201342.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"4495_CR16","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41584-020-0413-5","volume":"16","author":"G Nygaard","year":"2020","unstructured":"Nygaard G, Firestein GS. Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat Rev Rheumatol. 2020;16(6):316\u201333.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"4495_CR17","doi-asserted-by":"publisher","first-page":"102758","DOI":"10.1016\/j.autrev.2021.102758","volume":"20","author":"M-A Boutet","year":"2021","unstructured":"Boutet M-A, et al. Novel insights into macrophage diversity in rheumatoid arthritis synovium. Autoimmun Rev. 2021;20(3):102758.","journal-title":"Autoimmun Rev"},{"issue":"7","key":"4495_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41584-022-00793-5","volume":"18","author":"N Komatsu","year":"2022","unstructured":"Komatsu N, Takayanagi H. Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions. Nat Rev Rheumatol. 2022;18(7):415\u201329.","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"4495_CR19","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/art.41752","volume":"73","author":"L Fraenkel","year":"2021","unstructured":"Fraenkel L, et al. 2021 American college of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol (Hoboken N J). 2021;73(7):1108\u201323.","journal-title":"Arthritis Rheumatol (Hoboken N J)"},{"key":"4495_CR20","doi-asserted-by":"crossref","unstructured":"Smolen JS et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis, 2023. 82(1).","DOI":"10.1136\/ard-2022-223356corr1"},{"issue":"Suppl 2","key":"4495_CR21","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1007\/s000110050284","volume":"47","author":"JR Vane","year":"1998","unstructured":"Vane JR, Botting RM. Anti-inflammatory drugs and their mechanism of action. Inflamm Research: Official J Eur Histamine Res Soc\u2026 Et Al]. 1998;47(Suppl 2):S78\u201387.","journal-title":"Inflamm Research: Official J Eur Histamine Res Soc\u2026 Et Al]"},{"issue":"9","key":"4495_CR22","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41569-020-0366-z","volume":"17","author":"A-M Schjerning","year":"2020","unstructured":"Schjerning A-M, McGettigan P, Gislason G. Cardiovascular effects and safety of (non-aspirin) NSAIDs. Nat Rev Cardiol. 2020;17(9):574\u201384.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"4495_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nri.2017.1","volume":"17","author":"DW Cain","year":"2017","unstructured":"Cain DW, Cidlowski JA. Immune regulation by glucocorticoids. Nat Rev Immunol. 2017;17(4):233\u201347.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"4495_CR24","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00281-020-00827-8","volume":"42","author":"A Shimba","year":"2020","unstructured":"Shimba A, Ikuta K. Control of immunity by glucocorticoids in health and disease. Semin Immunopathol. 2020;42(6):669\u201380.","journal-title":"Semin Immunopathol"},{"issue":"13","key":"4495_CR25","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: A review. JAMA. 2018;320(13):1360\u201372.","journal-title":"JAMA"},{"issue":"1","key":"4495_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrrheum.2016.178","volume":"13","author":"BN Cronstein","year":"2017","unstructured":"Cronstein BN, Sitkovsky M. Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases. Nat Rev Rheumatol. 2017;13(1):41\u201351.","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"4495_CR27","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1136\/ard.59.11.841","volume":"59","author":"FC Breedveld","year":"2000","unstructured":"Breedveld FC, Dayer JM. Leflunomide: mode of action in the treatment of rheumatoid arthritis. Ann Rheum Dis. 2000;59(11):841\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4495_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","volume":"16","author":"BN Cronstein","year":"2020","unstructured":"Cronstein BN, Aune TM. Methotrexate and its mechanisms of action in inflammatory arthritis. Nat Rev Rheumatol. 2020;16(3):145\u201354.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"4495_CR29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","volume":"16","author":"E Schrezenmeier","year":"2020","unstructured":"Schrezenmeier E, D\u00f6rner T. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol. 2020;16(3):155\u201366.","journal-title":"Nat Rev Rheumatol"},{"key":"4495_CR30","doi-asserted-by":"crossref","unstructured":"Jiang H, et al. Molecular mechanisms and clinical application of iguratimod: A review. Volume 122. Biomedicine & Pharmacotherapy\u2009=\u2009Biomedecine & Pharmacotherapie; 2020. p. 109704.","DOI":"10.1016\/j.biopha.2019.109704"},{"issue":"6","key":"4495_CR31","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2217\/imt-2017-0155","volume":"10","author":"S Zhao","year":"2018","unstructured":"Zhao S, Mysler E, Moots RJ. Etanercept for the treatment of rheumatoid arthritis. Immunotherapy. 2018;10(6):433\u201345.","journal-title":"Immunotherapy"},{"issue":"3","key":"4495_CR32","first-page":"CD003785","volume":"2002","author":"B Blumenauer","year":"2002","unstructured":"Blumenauer B, et al. Infliximab for the treatment of rheumatoid arthritis. Cochrane Database Syst Rev. 2002;2002(3):CD003785.","journal-title":"Cochrane Database Syst Rev"},{"key":"4495_CR33","doi-asserted-by":"publisher","first-page":"638444","DOI":"10.3389\/fimmu.2021.638444","volume":"12","author":"X Lu","year":"2021","unstructured":"Lu X, et al. Efficacy and safety of adalimumab biosimilars: current critical clinical data in rheumatoid arthritis. Front Immunol. 2021;12:638444.","journal-title":"Front Immunol"},{"issue":"1","key":"4495_CR34","first-page":"CD008341","volume":"2010","author":"JA Singh","year":"2010","unstructured":"Singh JA, Noorbaloochi S, Singh G. Golimumab for rheumatoid arthritis. Cochrane Database Syst Rev. 2010;2010(1):CD008341.","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"4495_CR35","first-page":"CD007649","volume":"9","author":"V Ruiz Garcia","year":"2017","unstructured":"Ruiz Garcia V, et al. Certolizumab Pegol (CDP870) for rheumatoid arthritis in adults. Cochrane Database Syst Rev. 2017;9(9):CD007649.","journal-title":"Cochrane Database Syst Rev"},{"issue":"24","key":"4495_CR36","first-page":"7833","volume":"25","author":"MK Bedaiwi","year":"2021","unstructured":"Bedaiwi MK, Almaghlouth I, Omair MA. Effectiveness and adverse effects of Anakinra in treatment of rheumatoid arthritis: a systematic review. Eur Rev Med Pharmacol Sci. 2021;25(24):7833\u20139.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"17","key":"4495_CR37","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s40265-017-0829-7","volume":"77","author":"LJ Scott","year":"2017","unstructured":"Scott LJ. Tocilizumab: A review in rheumatoid arthritis. Drugs. 2017;77(17):1865\u201379.","journal-title":"Drugs"},{"issue":"9","key":"4495_CR38","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s40265-018-0929-z","volume":"78","author":"YN Lamb","year":"2018","unstructured":"Lamb YN, Deeks ED. Sarilumab: A review in moderate to severe rheumatoid arthritis. Drugs. 2018;78(9):929\u201340.","journal-title":"Drugs"},{"issue":"11","key":"4495_CR39","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s40265-017-0775-4","volume":"77","author":"HA Blair","year":"2017","unstructured":"Blair HA, Deeks ED. Abatacept: A review in rheumatoid arthritis. Drugs. 2017;77(11):1221\u201333.","journal-title":"Drugs"},{"key":"4495_CR40","first-page":"CD007356","volume":"1","author":"MA Lopez-Olivo","year":"2015","unstructured":"Lopez-Olivo MA, et al. Rituximab for rheumatoid arthritis. Cochrane Database Syst Rev. 2015;1:CD007356.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"4495_CR41","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","volume":"8","author":"C Xue","year":"2023","unstructured":"Xue C, et al. Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer. Signal Transduct Target Therapy. 2023;8(1):204.","journal-title":"Signal Transduct Target Therapy"},{"issue":"12","key":"4495_CR42","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nrd.2017.201","volume":"16","author":"DM Schwartz","year":"2017","unstructured":"Schwartz DM, et al. JAK Inhibition as a therapeutic strategy for immune and inflammatory diseases. Nat Rev Drug Discov. 2017;16(12):843\u201362.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"4495_CR43","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/13543784.2023.2199919","volume":"32","author":"S Kubo","year":"2023","unstructured":"Kubo S, Nakayamada S, Tanaka Y. JAK inhibitors for rheumatoid arthritis. Expert Opin Investig Drugs. 2023;32(4):333\u201344.","journal-title":"Expert Opin Investig Drugs"},{"issue":"18","key":"4495_CR44","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s40265-017-0835-9","volume":"77","author":"S Dhillon","year":"2017","unstructured":"Dhillon S. Tofacitinib: A review in rheumatoid arthritis. Drugs. 2017;77(18):1987\u20132001.","journal-title":"Drugs"},{"issue":"7","key":"4495_CR45","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s40265-018-0908-4","volume":"78","author":"ZT Al-Salama","year":"2018","unstructured":"Al-Salama ZT, Scott LJ. Baricitinib: A review in rheumatoid arthritis. Drugs. 2018;78(7):761\u201372.","journal-title":"Drugs"},{"issue":"8","key":"4495_CR46","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s40261-021-01055-0","volume":"41","author":"ES Kim","year":"2021","unstructured":"Kim ES, Keam SJ. Filgotinib in rheumatoid arthritis: A profile of its use. Clin Drug Investig. 2021;41(8):741\u20139.","journal-title":"Clin Drug Investig"},{"key":"4495_CR47","doi-asserted-by":"crossref","unstructured":"Sanmart\u00ed R, Corominas H. Upadacitinib for patients with rheumatoid arthritis: A comprehensive review. J Clin Med, 2023. 12(5).","DOI":"10.3390\/jcm12051734"},{"issue":"5","key":"4495_CR48","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1080\/14397595.2020.1794103","volume":"30","author":"Y Kaneko","year":"2020","unstructured":"Kaneko Y. Efficacy and safety of Peficitinib in rheumatoid arthritis. Mod Rheumatol. 2020;30(5):773\u20138.","journal-title":"Mod Rheumatol"},{"key":"4495_CR49","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/bmb\/ldq007","volume":"94","author":"JH Tayar","year":"2010","unstructured":"Tayar JH, Suarez-Almazor ME. New Understanding and approaches to treatment in rheumatoid arthritis. Br Med Bull. 2010;94:201\u201314.","journal-title":"Br Med Bull"},{"key":"4495_CR50","doi-asserted-by":"crossref","unstructured":"van Everdingen AA et al. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial. Ann Intern Med, 2002. 136(1).","DOI":"10.7326\/0003-4819-136-1-200201010-00006"},{"issue":"Suppl 3","key":"4495_CR51","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/ar4174","volume":"15","author":"LJ Crofford","year":"2013","unstructured":"Crofford LJ. Use of NSAIDs in treating patients with arthritis. Arthritis Res Therapy. 2013;15(Suppl 3):S2.","journal-title":"Arthritis Res Therapy"},{"issue":"5","key":"4495_CR52","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1210\/er.2018-00097","volume":"39","author":"RS Hardy","year":"2018","unstructured":"Hardy RS, et al. Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy. Endocr Rev. 2018;39(5):519\u201348.","journal-title":"Endocr Rev"},{"key":"4495_CR53","doi-asserted-by":"crossref","unstructured":"Lin Y-J, Anzaghe M, Sch\u00fclke S. Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cells, 2020. 9(4).","DOI":"10.3390\/cells9040880"},{"key":"4495_CR54","doi-asserted-by":"crossref","unstructured":"Gagliardi A et al. Real-World safety profile of biologics used in rheumatology: A Six-Year observational pharmacovigilance study in the Calabria region. Pharmaceutics, 2022. 14(11).","DOI":"10.3390\/pharmaceutics14112328"},{"issue":"4","key":"4495_CR55","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy. 2006;8(4):315\u20137.","journal-title":"Cytotherapy"},{"issue":"2","key":"4495_CR56","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nrm3049","volume":"12","author":"C Nombela-Arrieta","year":"2011","unstructured":"Nombela-Arrieta C, Ritz J, Silberstein LE. The elusive nature and function of mesenchymal stem cells. Nat Rev Mol Cell Biol. 2011;12(2):126\u201331.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"4495_CR57","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41581-018-0023-5","volume":"14","author":"Y Shi","year":"2018","unstructured":"Shi Y, et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol. 2018;14(8):493\u2013507.","journal-title":"Nat Rev Nephrol"},{"key":"4495_CR58","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/1479-5876-9-181","volume":"9","author":"JC Ra","year":"2011","unstructured":"Ra JC, et al. Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells. J Translational Med. 2011;9:181.","journal-title":"J Translational Med"},{"issue":"1","key":"4495_CR59","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10067-011-1816-0","volume":"31","author":"J Liang","year":"2012","unstructured":"Liang J, et al. Allogeneic mesenchymal stem cells transplantation in patients with refractory RA. Clin Rheumatol. 2012;31(1):157\u201361.","journal-title":"Clin Rheumatol"},{"issue":"24","key":"4495_CR60","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1089\/scd.2013.0023","volume":"22","author":"L Wang","year":"2013","unstructured":"Wang L, et al. Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy. Stem Cells Dev. 2013;22(24):3192\u2013202.","journal-title":"Stem Cells Dev"},{"issue":"1","key":"4495_CR61","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1136\/annrheumdis-2015-208918","volume":"76","author":"JM \u00c1lvaro-Gracia","year":"2017","unstructured":"\u00c1lvaro-Gracia JM, et al. Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase ib\/iia clinical trial. Ann Rheum Dis. 2017;76(1):196\u2013202.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 2","key":"4495_CR62","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1136\/annrheumdis-2017-eular.1106","volume":"76","author":"S Kafaja","year":"2017","unstructured":"Kafaja S, et al. FRI0220 allogeneic mesenchymal precursor cells (MPCS): a novel approach to treating biologic refractory rheumatoid arthritis. Ann Rheum Dis. 2017;76(Suppl 2):566.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"4495_CR63","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jcyt.2017.12.009","volume":"20","author":"S Shadmanfar","year":"2018","unstructured":"Shadmanfar S, et al. Intra-articular knee implantation of autologous bone marrow-derived mesenchymal stromal cells in rheumatoid arthritis patients with knee involvement: results of a randomized, triple-blind, placebo-controlled phase 1\/2 clinical trial. Cytotherapy. 2018;20(4):499\u2013506.","journal-title":"Cytotherapy"},{"issue":"9","key":"4495_CR64","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/sctm.18-0031","volume":"7","author":"EH Park","year":"2018","unstructured":"Park EH, et al. Intravenous infusion of umbilical cord Blood-Derived mesenchymal stem cells in rheumatoid arthritis: A phase Ia clinical trial. Stem Cells Translational Med. 2018;7(9):636\u201342.","journal-title":"Stem Cells Translational Med"},{"issue":"1","key":"4495_CR65","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12967-018-1541-4","volume":"16","author":"Y Yang","year":"2018","unstructured":"Yang Y, et al. Serum IFN-\u03b3 levels predict the therapeutic effect of mesenchymal stem cell transplantation in active rheumatoid arthritis. J Translational Med. 2018;16(1):165.","journal-title":"J Translational Med"},{"key":"4495_CR66","doi-asserted-by":"crossref","unstructured":"Ghoryani M, et al. Amelioration of clinical symptoms of patients with refractory rheumatoid arthritis following treatment with autologous bone marrow-derived mesenchymal stem cells: A successful clinical trial in Iran. Volume 109. Biomedicine & Pharmacotherapy\u2009=\u2009Biomedecine & Pharmacotherapie; 2019. pp. 1834\u201340.","DOI":"10.1016\/j.biopha.2018.11.056"},{"key":"4495_CR67","doi-asserted-by":"crossref","unstructured":"Wang L, et al. Efficacy and safety of umbilical cord mesenchymal stem cell therapy for rheumatoid arthritis patients: A prospective phase I\/II study. Volume 13. Drug Design, Development and Therapy; 2019. pp. 4331\u201340.","DOI":"10.2147\/DDDT.S225613"},{"issue":"10","key":"4495_CR68","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1136\/annrheumdis-2020-217798","volume":"79","author":"X He","year":"2020","unstructured":"He X, et al. Combination of human umbilical cord mesenchymal stem (stromal) cell transplantation with IFN-\u03b3 treatment synergistically improves the clinical outcomes of patients with rheumatoid arthritis. Ann Rheum Dis. 2020;79(10):1298\u2013304.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4495_CR69","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13287-022-02763-w","volume":"13","author":"R Vij","year":"2022","unstructured":"Vij R, et al. Safety and efficacy of autologous, adipose-derived mesenchymal stem cells in patients with rheumatoid arthritis: a phase i\/iia, open-label, non-randomized pilot trial. Stem Cell Res Ther. 2022;13(1):88.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"4495_CR70","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2174\/1574888X11308020005","volume":"8","author":"AK Batsali","year":"2013","unstructured":"Batsali AK, et al. Mesenchymal stem cells derived from wharton\u2019s jelly of the umbilical cord: biological properties and emerging clinical applications. Curr Stem Cell Res Therapy. 2013;8(2):144\u201355.","journal-title":"Curr Stem Cell Res Therapy"},{"key":"4495_CR71","doi-asserted-by":"crossref","unstructured":"Gilkeson GS. Safety and efficacy of mesenchymal stromal cells and other cellular therapeutics in rheumatic diseases in 2022: A review of what we know so Far. Volume 74. Arthritis & Rheumatology; 2022. pp. 752\u201365. (Hoboken, N.J.). 5.","DOI":"10.1002\/art.42081"},{"issue":"9","key":"4495_CR72","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","volume":"41","author":"N Song","year":"2020","unstructured":"Song N, Scholtemeijer M, Shah K. Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential. Trends Pharmacol Sci. 2020;41(9):653\u201364.","journal-title":"Trends Pharmacol Sci"},{"issue":"5","key":"4495_CR73","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1002\/eji.200425405","volume":"35","author":"A Augello","year":"2005","unstructured":"Augello A, et al. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur J Immunol. 2005;35(5):1482\u201390.","journal-title":"Eur J Immunol"},{"issue":"3","key":"4495_CR74","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/stem.2509","volume":"35","author":"LC Davies","year":"2017","unstructured":"Davies LC, et al. Mesenchymal stromal cell secretion of programmed Death-1 ligands regulates T cell mediated immunosuppression. Stem Cells. 2017;35(3):766\u201376.","journal-title":"Stem Cells"},{"issue":"5","key":"4495_CR75","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.stem.2012.03.007","volume":"10","author":"K Akiyama","year":"2012","unstructured":"Akiyama K, et al. Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-\/FAS-mediated T cell apoptosis. Cell Stem Cell. 2012;10(5):544\u201355.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"4495_CR76","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1182\/blood-2006-02-002246","volume":"109","author":"K Sato","year":"2007","unstructured":"Sato K, et al. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood. 2007;109(1):228\u201334.","journal-title":"Blood"},{"issue":"5","key":"4495_CR77","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1158\/0008-5472.CAN-13-1656","volume":"74","author":"W Ling","year":"2014","unstructured":"Ling W, et al. Mesenchymal stem cells use IDO to regulate immunity in tumor microenvironment. Cancer Res. 2014;74(5):1576\u201387.","journal-title":"Cancer Res"},{"issue":"1","key":"4495_CR78","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","volume":"5","author":"RH Lee","year":"2009","unstructured":"Lee RH, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 2009;5(1):54\u201363.","journal-title":"Cell Stem Cell"},{"issue":"26","key":"4495_CR79","doi-asserted-by":"publisher","first-page":"6576","DOI":"10.1182\/blood-2009-02-203943","volume":"113","author":"GM Spaggiari","year":"2009","unstructured":"Spaggiari GM, et al. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature dcs: central role of MSC-derived prostaglandin E2. Blood. 2009;113(26):6576\u201383.","journal-title":"Blood"},{"issue":"2","key":"4495_CR80","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/stem.2254","volume":"34","author":"P Luz-Crawford","year":"2016","unstructured":"Luz-Crawford P, et al. Mesenchymal stem cell-Derived Interleukin 1 receptor antagonist promotes macrophage polarization and inhibits B cell differentiation. Stem Cells. 2016;34(2):483\u201392.","journal-title":"Stem Cells"},{"issue":"8","key":"4495_CR81","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1634\/stemcells.2006-0548","volume":"25","author":"F Djouad","year":"2007","unstructured":"Djouad F, et al. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells. 2007;25(8):2025\u201332.","journal-title":"Stem Cells"},{"key":"4495_CR82","doi-asserted-by":"crossref","unstructured":"Chae D-S, Park Y-J, Kim S-W. Anti-Arthritogenic property of Interleukin 10-Expressing human amniotic MSCs generated by gene editing in Collagen-Induced arthritis. Int J Mol Sci, 2022. 23(14).","DOI":"10.3390\/ijms23147913"},{"issue":"1","key":"4495_CR83","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1365-2249.2009.03874.x","volume":"156","author":"K English","year":"2009","unstructured":"English K, et al. Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4\u2009+\u2009CD25(High) forkhead box P3\u2009+\u2009regulatory T cells. Clin Exp Immunol. 2009;156(1):149\u201360.","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"4495_CR84","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1182\/blood-2007-02-075481","volume":"110","author":"D Chabannes","year":"2007","unstructured":"Chabannes D, et al. A role for Heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood. 2007;110(10):3691\u20134.","journal-title":"Blood"},{"issue":"1","key":"4495_CR85","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1634\/stemcells.2007-0554","volume":"26","author":"Z Selmani","year":"2008","unstructured":"Selmani Z, et al. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4\u2009+\u2009CD25highFOXP3\u2009+\u2009regulatory T cells. Stem Cells. 2008;26(1):212\u201322.","journal-title":"Stem Cells"},{"issue":"1","key":"4495_CR86","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13287-020-01612-y","volume":"11","author":"Q-H Chen","year":"2020","unstructured":"Chen Q-H, et al. Mesenchymal stem cells regulate the Th17\/Treg cell balance partly through hepatocyte growth factor in vitro. Stem Cell Res Ther. 2020;11(1):91.","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"4495_CR87","doi-asserted-by":"publisher","first-page":"5113","DOI":"10.4049\/jimmunol.0901566","volume":"183","author":"Y-S Kim","year":"2009","unstructured":"Kim Y-S, et al. Vascular endothelial growth factor is a key mediator in the development of T cell priming and its polarization to type 1 and type 17 T helper cells in the airways. J Immunol (Baltimore Md: 1950). 2009;183(8):5113\u201320.","journal-title":"J Immunol (Baltimore Md: 1950)"},{"issue":"2","key":"4495_CR88","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","volume":"2","author":"G Ren","year":"2008","unstructured":"Ren G, et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008;2(2):141\u201350.","journal-title":"Cell Stem Cell"},{"issue":"6","key":"4495_CR89","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41423-023-00998-y","volume":"20","author":"P Li","year":"2023","unstructured":"Li P, et al. Immunomodulatory properties of mesenchymal stem cells\/dental stem cells and their therapeutic applications. Cell Mol Immunol. 2023;20(6):558\u201369.","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"4495_CR90","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.stem.2013.09.006","volume":"13","author":"ME Bernardo","year":"2013","unstructured":"Bernardo ME, Fibbe WE. Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell. 2013;13(4):392\u2013402.","journal-title":"Cell Stem Cell"},{"key":"4495_CR91","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3389\/fimmu.2015.00384","volume":"6","author":"M Mellado","year":"2015","unstructured":"Mellado M, et al. T cell migration in rheumatoid arthritis. Front Immunol. 2015;6:384.","journal-title":"Front Immunol"},{"issue":"1","key":"4495_CR92","first-page":"114","volume":"18","author":"R Baharlou","year":"2019","unstructured":"Baharlou R, et al. Immunomodulatory effects of human adipose Tissue-derived mesenchymal stem cells on T cell subsets in patients with rheumatoid arthritis. Iran J Allergy Asthma Immunol. 2019;18(1):114\u20139.","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"5","key":"4495_CR93","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00296-019-04296-7","volume":"39","author":"G Vasilev","year":"2019","unstructured":"Vasilev G, et al. Secretory factors produced by adipose mesenchymal stem cells downregulate Th17 and increase Treg cells in peripheral blood mononuclear cells from rheumatoid arthritis patients. Rheumatol Int. 2019;39(5):819\u201326.","journal-title":"Rheumatol Int"},{"issue":"6","key":"4495_CR94","first-page":"203","volume":"6","author":"M Vohra","year":"2020","unstructured":"Vohra M, et al. Human umbilical cord-derived mesenchymal stem cells induce tissue repair and regeneration in collagen-induced arthritis in rats. J Clin Translational Res. 2020;6(6):203\u201316.","journal-title":"J Clin Translational Res"},{"key":"4495_CR95","doi-asserted-by":"publisher","first-page":"105687","DOI":"10.1016\/j.intimp.2019.105687","volume":"74","author":"D Ma","year":"2019","unstructured":"Ma D, et al. Immunomodulatory effect of human umbilical cord mesenchymal stem cells on T lymphocytes in rheumatoid arthritis. Int Immunopharmacol. 2019;74:105687.","journal-title":"Int Immunopharmacol"},{"key":"4495_CR96","doi-asserted-by":"publisher","first-page":"12777","DOI":"10.1038\/srep12777","volume":"5","author":"R Liu","year":"2015","unstructured":"Liu R, et al. Allogeneic mesenchymal stem cells inhibited T follicular helper cell generation in rheumatoid arthritis. Sci Rep. 2015;5:12777.","journal-title":"Sci Rep"},{"issue":"7","key":"4495_CR97","first-page":"1134","volume":"13","author":"Y Yu","year":"2019","unstructured":"Yu Y, et al. Therapeutic effect of long-interval repeated intravenous administration of human umbilical cord blood-derived mesenchymal stem cells in DBA\/1 mice with collagen-induced arthritis. J Tissue Eng Regen Med. 2019;13(7):1134\u201342.","journal-title":"J Tissue Eng Regen Med"},{"key":"4495_CR98","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3389\/fimmu.2019.00798","volume":"10","author":"N Luque-Campos","year":"2019","unstructured":"Luque-Campos N, et al. Mesenchymal stem cells improve rheumatoid arthritis progression by controlling memory T cell response. Front Immunol. 2019;10:798.","journal-title":"Front Immunol"},{"key":"4495_CR99","doi-asserted-by":"publisher","first-page":"1161148","DOI":"10.3389\/fimmu.2023.1161148","volume":"14","author":"Y Suwa","year":"2023","unstructured":"Suwa Y, et al. The role of dendritic cells and their immunometabolism in rheumatoid arthritis. Front Immunol. 2023;14:1161148.","journal-title":"Front Immunol"},{"issue":"6","key":"4495_CR100","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1016\/j.apsb.2023.04.003","volume":"13","author":"G Shi","year":"2023","unstructured":"Shi G, et al. Bone-derived MSCs encapsulated in alginate hydrogel prevent collagen-induced arthritis in mice through the activation of adenosine A2A\/2B receptors in tolerogenic dendritic cells. Acta Pharm Sinica B. 2023;13(6):2778\u201394.","journal-title":"Acta Pharm Sinica B"},{"issue":"12","key":"4495_CR101","doi-asserted-by":"publisher","first-page":"e2524","DOI":"10.1038\/cddis.2016.442","volume":"7","author":"T-H Shin","year":"2016","unstructured":"Shin T-H, et al. Human umbilical cord blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis. Cell Death Dis. 2016;7(12):e2524.","journal-title":"Cell Death Dis"},{"issue":"10","key":"4495_CR102","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nrrheum.2014.80","volume":"10","author":"HL Wright","year":"2014","unstructured":"Wright HL, Moots RJ, Edwards SW. The multifactorial role of neutrophils in rheumatoid arthritis. Nat Rev Rheumatol. 2014;10(10):593\u2013601.","journal-title":"Nat Rev Rheumatol"},{"key":"4495_CR103","doi-asserted-by":"publisher","first-page":"110334","DOI":"10.1016\/j.clim.2024.110334","volume":"266","author":"Z Li","year":"2024","unstructured":"Li Z, Lu Q. The role of neutrophils in autoimmune diseases. Clin Immunol (Orlando Fla). 2024;266:110334.","journal-title":"Clin Immunol (Orlando Fla)"},{"issue":"12","key":"4495_CR104","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1002\/art.39313","volume":"67","author":"J Spengler","year":"2015","unstructured":"Spengler J, et al. Release of active peptidyl arginine deiminases by neutrophils can explain production of extracellular citrullinated autoantigens in rheumatoid arthritis synovial fluid. Arthritis Rheumatol (Hoboken N J). 2015;67(12):3135\u201345.","journal-title":"Arthritis Rheumatol (Hoboken N J)"},{"key":"4495_CR105","doi-asserted-by":"crossref","unstructured":"Carmona-Rivera C et al. Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis. Sci Immunol, 2017. 2(10).","DOI":"10.1126\/sciimmunol.aag3358"},{"issue":"4","key":"4495_CR106","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/bph.13237","volume":"173","author":"MM Muley","year":"2016","unstructured":"Muley MM, et al. Neutrophil elastase induces inflammation and pain in mouse knee joints via activation of proteinase-activated receptor-2. Br J Pharmacol. 2016;173(4):766\u201377.","journal-title":"Br J Pharmacol"},{"key":"4495_CR107","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jare.2023.05.001","volume":"58","author":"J Zhao","year":"2024","unstructured":"Zhao J, et al. Infusion of GMSCs relieves autoimmune arthritis by suppressing the externalization of neutrophil extracellular traps via PGE2-PKA-ERK axis. J Adv Res. 2024;58:79\u201391.","journal-title":"J Adv Res"},{"key":"4495_CR108","doi-asserted-by":"publisher","first-page":"p8459281","DOI":"10.1155\/2019\/8459281","volume":"2019","author":"F Li","year":"2019","unstructured":"Li F, et al. Bone marrow mesenchymal stem cells decrease the expression of RANKL in Collagen-Induced arthritis rats via reducing the levels of IL-22. J Immunol Res. 2019;2019:p8459281.","journal-title":"J Immunol Res"},{"key":"4495_CR109","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.ebiom.2019.04.058","volume":"43","author":"Y Luo","year":"2019","unstructured":"Luo Y, et al. Human gingival tissue-derived MSC suppress osteoclastogenesis and bone erosion via CD39-adenosine signal pathway in autoimmune arthritis. EBioMedicine. 2019;43:620\u201331.","journal-title":"EBioMedicine"},{"issue":"6","key":"4495_CR110","doi-asserted-by":"publisher","first-page":"R210","DOI":"10.1186\/ar3187","volume":"12","author":"Y Liu","year":"2010","unstructured":"Liu Y, et al. Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Res Therapy. 2010;12(6):R210.","journal-title":"Arthritis Res Therapy"},{"issue":"10","key":"4495_CR111","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1136\/annrheumdis-2011-200985","volume":"71","author":"A Papadopoulou","year":"2012","unstructured":"Papadopoulou A, et al. Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis. Ann Rheum Dis. 2012;71(10):1733\u201340.","journal-title":"Ann Rheum Dis"},{"key":"4495_CR112","doi-asserted-by":"publisher","first-page":"137695","DOI":"10.1155\/2015\/137695","volume":"2015","author":"C Zhao","year":"2015","unstructured":"Zhao C, et al. Umbilical Cord-Derived mesenchymal stem cells inhibit Cadherin-11 expression by Fibroblast-Like synoviocytes in rheumatoid arthritis. J Immunol Res. 2015;2015:137695.","journal-title":"J Immunol Res"},{"issue":"1","key":"4495_CR113","doi-asserted-by":"publisher","first-page":"15344","DOI":"10.1038\/s41598-023-42585-1","volume":"13","author":"Y-H Chiu","year":"2023","unstructured":"Chiu Y-H, et al. IL-1\u03b2 stimulated human umbilical cord mesenchymal stem cells ameliorate rheumatoid arthritis via inducing apoptosis of fibroblast-like synoviocytes. Sci Rep. 2023;13(1):15344.","journal-title":"Sci Rep"},{"issue":"6","key":"4495_CR114","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1136\/ard-2022-222554","volume":"82","author":"C Ospelt","year":"2023","unstructured":"Ospelt C. Site of invasion revisited: epigenetic drivers of joint destruction in RA. Ann Rheum Dis. 2023;82(6):734\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4495_CR115","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1002\/art.39036","volume":"67","author":"M Kondo","year":"2015","unstructured":"Kondo M, et al. Contribution of the Interleukin-6\/STAT-3 signaling pathway to chondrogenic differentiation of human mesenchymal stem cells. Arthritis Rheumatol (Hoboken N J). 2015;67(5):1250\u201360.","journal-title":"Arthritis Rheumatol (Hoboken N J)"},{"issue":"1","key":"4495_CR116","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13287-020-01684-w","volume":"11","author":"J Gao","year":"2020","unstructured":"Gao J, et al. Bone marrow mesenchymal stem cells improve bone erosion in collagen-induced arthritis by inhibiting osteoclasia-related factors and differentiating into chondrocytes. Stem Cell Res Ther. 2020;11(1):171.","journal-title":"Stem Cell Res Ther"},{"key":"4495_CR117","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.biomaterials.2017.10.046","volume":"196","author":"B-D Sui","year":"2019","unstructured":"Sui B-D, et al. Stem cell-based bone regeneration in diseased microenvironments: challenges and solutions. Biomaterials. 2019;196:18\u201330.","journal-title":"Biomaterials"},{"issue":"9","key":"4495_CR118","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.5966\/sctm.2015-0347","volume":"5","author":"B Sui","year":"2016","unstructured":"Sui B, et al. Allogeneic mesenchymal stem cell therapy promotes osteoblastogenesis and prevents Glucocorticoid-Induced osteoporosis. Stem Cells Translational Med. 2016;5(9):1238\u201346.","journal-title":"Stem Cells Translational Med"},{"key":"4495_CR119","doi-asserted-by":"publisher","first-page":"16009","DOI":"10.1038\/boneres.2016.9","volume":"4","author":"M Wu","year":"2016","unstructured":"Wu M, Chen G, Li Y-P. TGF-\u03b2 and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease. Bone Res. 2016;4:16009.","journal-title":"Bone Res"},{"issue":"1","key":"4495_CR120","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","volume":"12","author":"T Wada","year":"2006","unstructured":"Wada T, et al. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med. 2006;12(1):17\u201325.","journal-title":"Trends Mol Med"},{"issue":"2","key":"4495_CR121","doi-asserted-by":"publisher","first-page":"e12877","DOI":"10.1111\/sji.12877","volume":"92","author":"Q Chang","year":"2020","unstructured":"Chang Q, et al. Adipose-derived mesenchymal stromal cells suppress osteoclastogenesis and bone erosion in collagen-induced arthritis. Scand J Immunol. 2020;92(2):e12877.","journal-title":"Scand J Immunol"},{"issue":"10","key":"4495_CR122","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1089\/scd.2009.0021","volume":"18","author":"H Zhu","year":"2009","unstructured":"Zhu H, et al. Tumor necrosis factor-alpha alters the modulatory effects of mesenchymal stem cells on osteoclast formation and function. Stem Cells Dev. 2009;18(10):1473\u201384.","journal-title":"Stem Cells Dev"},{"issue":"1","key":"4495_CR123","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13287-023-03295-7","volume":"14","author":"X Zhu","year":"2023","unstructured":"Zhu X, et al. Research progress of engineered mesenchymal stem cells and their derived exosomes and their application in autoimmune\/inflammatory diseases. Stem Cell Res Ther. 2023;14(1):71.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4495_CR124","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13287-022-02822-2","volume":"13","author":"M Li","year":"2022","unstructured":"Li M, et al. Potential pre-activation strategies for improving therapeutic efficacy of mesenchymal stem cells: current status and future prospects. Stem Cell Res Ther. 2022;13(1):146.","journal-title":"Stem Cell Res Ther"},{"key":"4495_CR125","doi-asserted-by":"publisher","first-page":"26851","DOI":"10.1038\/srep26851","volume":"6","author":"J-Y Lim","year":"2016","unstructured":"Lim J-Y, et al. Enhanced immunoregulation of mesenchymal stem cells by IL-10-producing type 1 regulatory T cells in collagen-induced arthritis. Sci Rep. 2016;6:26851.","journal-title":"Sci Rep"},{"key":"4495_CR126","doi-asserted-by":"publisher","first-page":"43188","DOI":"10.1038\/srep43188","volume":"7","author":"R Li","year":"2017","unstructured":"Li R, et al. Synergistic suppression of autoimmune arthritis through concurrent treatment with tolerogenic DC and MSC. Sci Rep. 2017;7:43188.","journal-title":"Sci Rep"},{"key":"4495_CR127","doi-asserted-by":"crossref","unstructured":"Harrell CR et al. Mesenchymal stem Cell-Derived exosomes and other extracellular vesicles as new remedies in the therapy of inflammatory diseases. Cells, 2019. 8(12).","DOI":"10.3390\/cells8121605"},{"issue":"1","key":"4495_CR128","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s13287-021-02402-w","volume":"12","author":"S-T Wei","year":"2021","unstructured":"Wei S-T, et al. Gain of CXCR7 function with mesenchymal stem cell therapy ameliorates experimental arthritis via enhancing tissue regeneration and Immunomodulation. Stem Cell Res Ther. 2021;12(1):314.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4495_CR129","doi-asserted-by":"publisher","first-page":"112945","DOI":"10.1016\/j.yexcr.2021.112945","volume":"410","author":"T He","year":"2022","unstructured":"He T, Sun S. Evaluation of the therapeutic efficacy of human bone marrow mesenchymal stem cells with COX-2 silence and TGF-\u03b23 overexpression in rabbits with antigen-induced arthritis. Exp Cell Res. 2022;410(1):112945.","journal-title":"Exp Cell Res"},{"issue":"4","key":"4495_CR130","doi-asserted-by":"publisher","first-page":"245","DOI":"10.14348\/molcells.2021.0037","volume":"44","author":"D-S Chae","year":"2021","unstructured":"Chae D-S, et al. Genome edited Sirt1-Overexpressing human mesenchymal stem cells exhibit therapeutic effects in treating Collagen-Induced arthritis. Mol Cells. 2021;44(4):245\u201353.","journal-title":"Mol Cells"},{"issue":"5","key":"4495_CR131","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/term.3191","volume":"15","author":"D-S Chae","year":"2021","unstructured":"Chae D-S, et al. TGF-\u03b21 overexpressing human MSCs generated using gene editing show robust therapeutic potential for treating collagen-induced arthritis. J Tissue Eng Regen Med. 2021;15(5):513\u201323.","journal-title":"J Tissue Eng Regen Med"},{"key":"4495_CR132","doi-asserted-by":"crossref","unstructured":"Chae D-S et al. BMP-2 Genome-Edited human MSCs protect against cartilage degeneration via suppression of IL-34 in Collagen-Induced arthritis. Int J Mol Sci, 2023. 24(9).","DOI":"10.3390\/ijms24098223"},{"issue":"1","key":"4495_CR133","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1186\/s13287-021-02602-4","volume":"12","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, et al. sTNFRII-Fc modification protects human UC-MSCs against apoptosis\/autophagy induced by TNF-\u03b1 and enhances their efficacy in alleviating inflammatory arthritis. Stem Cell Res Ther. 2021;12(1):535.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"4495_CR134","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3727\/096368915X688470","volume":"25","author":"EW Choi","year":"2016","unstructured":"Choi EW, et al. Effects of transplantation of CTLA4Ig-Overexpressing adipose Tissue-Derived mesenchymal stem cells in mice with sustained severe rheumatoid arthritis. Cell Transplant. 2016;25(2):243\u201359.","journal-title":"Cell Transplant"},{"issue":"1","key":"4495_CR135","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13287-018-0948-4","volume":"9","author":"K-W Kim","year":"2018","unstructured":"Kim K-W, et al. Epigenetic modification of mesenchymal stromal cells enhances their suppressive effects on the Th17 responses of cells from rheumatoid arthritis patients. Stem Cell Res Ther. 2018;9(1):208.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"4495_CR136","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1124\/jpet.119.259796","volume":"370","author":"S Cheng","year":"2019","unstructured":"Cheng S, et al. Engineered mesenchymal stem cells for targeting solid tumors: therapeutic potential beyond regenerative therapy. J Pharmacol Exp Ther. 2019;370(2):231\u201341.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"4495_CR137","doi-asserted-by":"publisher","first-page":"e0120596","DOI":"10.1371\/journal.pone.0120596","volume":"10","author":"H Liu","year":"2015","unstructured":"Liu H, et al. Remission of collagen-induced arthritis through combination therapy of microfracture and transplantation of thermogel-encapsulated bone marrow mesenchymal stem cells. PLoS ONE. 2015;10(3):e0120596.","journal-title":"PLoS ONE"},{"key":"4495_CR138","doi-asserted-by":"publisher","first-page":"121474","DOI":"10.1016\/j.biomaterials.2022.121474","volume":"283","author":"Y Lu","year":"2022","unstructured":"Lu Y, et al. Highly effective rheumatoid arthritis therapy by peptide-promoted nanomodification of mesenchymal stem cells. Biomaterials. 2022;283:121474.","journal-title":"Biomaterials"},{"key":"4495_CR139","doi-asserted-by":"crossref","unstructured":"Shin MJ et al. Inflammation-Targeting Mesenchymal Stem Cells Combined with Photothermal Treatment Attenuate Severe Joint Inflammation. Advanced Materials (Deerfield Beach, Fla.), 2024. 36(11): p. e2304333.","DOI":"10.1002\/adma.202304333"},{"issue":"1","key":"4495_CR140","doi-asserted-by":"publisher","first-page":"6758","DOI":"10.1038\/s41467-022-34481-5","volume":"13","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, et al. Nanozyme-reinforced hydrogel as a H2O2-driven oxygenerator for enhancing prosthetic interface osseointegration in rheumatoid arthritis therapy. Nat Commun. 2022;13(1):6758.","journal-title":"Nat Commun"},{"issue":"12","key":"4495_CR141","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1038\/s41565-023-01523-y","volume":"18","author":"S Koo","year":"2023","unstructured":"Koo S, et al. Ceria-vesicle nanohybrid therapeutic for modulation of innate and adaptive immunity in a collagen-induced arthritis model. Nat Nanotechnol. 2023;18(12):1502\u201314.","journal-title":"Nat Nanotechnol"},{"key":"4495_CR142","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.actbio.2020.12.005","volume":"121","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, et al. Infliximab-based self-healing hydrogel composite scaffold enhances stem cell survival, engraftment, and function in rheumatoid arthritis treatment. Acta Biomater. 2021;121:653\u201364.","journal-title":"Acta Biomater"},{"issue":"9","key":"4495_CR143","first-page":"e2206253","volume":"10","author":"H Zhu","year":"2023","unstructured":"Zhu H, et al. ECM-Inspired hydrogels with ADSCs encapsulation for rheumatoid arthritis treatment. Adv Sci (Weinheim Baden-Wurttemberg Germany). 2023;10(9):e2206253.","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"issue":"1","key":"4495_CR144","doi-asserted-by":"publisher","first-page":"10612","DOI":"10.1038\/s41598-023-37741-6","volume":"13","author":"Y-X Zeng","year":"2023","unstructured":"Zeng Y-X, et al. The effects of IL-1\u03b2 stimulated human umbilical cord mesenchymal stem cells on polarization and apoptosis of macrophages in rheumatoid arthritis. Sci Rep. 2023;13(1):10612.","journal-title":"Sci Rep"},{"issue":"4","key":"4495_CR145","first-page":"670","volume":"38","author":"K Yamagata","year":"2020","unstructured":"Yamagata K, et al. Soluble IL-6R promotes chondrogenic differentiation of mesenchymal stem cells to enhance the repair of articular cartilage defects using a rat model for rheumatoid arthritis. Clin Exp Rheumatol. 2020;38(4):670\u20139.","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"4495_CR146","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s12640-022-00544-0","volume":"40","author":"M-S Chen","year":"2022","unstructured":"Chen M-S, et al. Epigallocatechin-3-Gallate pretreatment improves autologous Adipose-derived stem cells against rheumatoid Arthritis-induced neuroinflammation in the brain of Collagen-induced rats. Neurotox Res. 2022;40(5):1223\u201334.","journal-title":"Neurotox Res"},{"issue":"10","key":"4495_CR147","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1111\/jcmm.12336","volume":"18","author":"L Guo","year":"2014","unstructured":"Guo L, et al. Epigenetic changes of mesenchymal stem cells in three-dimensional (3D) spheroids. J Cell Mol Med. 2014;18(10):2009\u201319.","journal-title":"J Cell Mol Med"},{"issue":"8","key":"4495_CR148","doi-asserted-by":"publisher","first-page":"584","DOI":"10.5966\/sctm.2013-0007","volume":"2","author":"N-C Cheng","year":"2013","unstructured":"Cheng N-C, et al. Short-term spheroid formation enhances the regenerative capacity of adipose-derived stem cells by promoting stemness, angiogenesis, and chemotaxis. Stem Cells Translational Med. 2013;2(8):584\u201394.","journal-title":"Stem Cells Translational Med"},{"issue":"11","key":"4495_CR149","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1002\/stem.1499","volume":"31","author":"TJ Bartosh","year":"2013","unstructured":"Bartosh TJ, et al. Dynamic compaction of human mesenchymal stem\/precursor cells into spheres self-activates caspase-dependent IL1 signaling to enhance secretion of modulators of inflammation and immunity (PGE2, TSG6, and STC1). Stem Cells. 2013;31(11):2443\u201356.","journal-title":"Stem Cells"},{"key":"4495_CR150","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fimmu.2020.00143","volume":"11","author":"AJ Burand","year":"2020","unstructured":"Burand AJ, et al. Aggregation of human mesenchymal stromal cells eliminates their ability to suppress human T cells. Front Immunol. 2020;11:143.","journal-title":"Front Immunol"},{"issue":"3","key":"4495_CR151","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jcyt.2013.09.004","volume":"16","author":"JA Zimmermann","year":"2014","unstructured":"Zimmermann JA, McDevitt TC. Pre-conditioning mesenchymal stromal cell spheroids for Immunomodulatory paracrine factor secretion. Cytotherapy. 2014;16(3):331\u201345.","journal-title":"Cytotherapy"},{"issue":"7","key":"4495_CR152","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1634\/stemcells.2007-0022","volume":"25","author":"IA Potapova","year":"2007","unstructured":"Potapova IA, et al. Mesenchymal stem cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro. Stem Cells. 2007;25(7):1761\u20138.","journal-title":"Stem Cells"},{"issue":"1","key":"4495_CR153","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1038\/s41598-020-60041-2","volume":"10","author":"H Ueyama","year":"2020","unstructured":"Ueyama H, et al. Local transplantation of adipose-derived stem cells has a significant therapeutic effect in a mouse model of rheumatoid arthritis. Sci Rep. 2020;10(1):3076.","journal-title":"Sci Rep"},{"issue":"12","key":"4495_CR154","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.7150\/thno.32945","volume":"9","author":"B-C Lee","year":"2019","unstructured":"Lee B-C, et al. Disease-specific primed human adult stem cells effectively ameliorate experimental atopic dermatitis in mice. Theranostics. 2019;9(12):3608\u201321.","journal-title":"Theranostics"},{"key":"4495_CR155","doi-asserted-by":"crossref","unstructured":"Tang W, et al. Neuroprotective effect of stroke pretreated mesenchymal stem cells against cerebral ischemia\/reperfusion injury in rats. World Neurosurgery; 2022. p. 165.","DOI":"10.1016\/j.wneu.2021.04.114"},{"issue":"6","key":"4495_CR156","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.autrev.2017.04.001","volume":"16","author":"F Rivellese","year":"2017","unstructured":"Rivellese F, et al. Mast cells in rheumatoid arthritis: friends or foes? Autoimmun Rev. 2017;16(6):557\u201363.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"4495_CR157","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1634\/stemcells.2005-0008","volume":"24","author":"M Krampera","year":"2006","unstructured":"Krampera M, et al. Role for interferon-gamma in the Immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells. 2006;24(2):386\u201398.","journal-title":"Stem Cells"},{"key":"4495_CR158","doi-asserted-by":"crossref","unstructured":"Haikal SM et al. Combination therapy of mesenchymal stromal cells and Interleukin-4 attenuates rheumatoid arthritis in a Collagen-Induced murine model. Cells, 2019. 8(8).","DOI":"10.3390\/cells8080823"},{"key":"4495_CR159","doi-asserted-by":"crossref","unstructured":"Li C-J et al. Enhancement of Mitochondrial Transfer by Antioxidants in Human Mesenchymal Stem Cells. Oxidative Medicine and Cellular Longevity, 2017. 2017: p. 8510805.","DOI":"10.1155\/2017\/8510805"},{"issue":"1","key":"4495_CR160","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/08916934.2018.1428956","volume":"51","author":"SS Abd-Elhalem","year":"2018","unstructured":"Abd-Elhalem SS, Haggag NZ, El-Shinnawy NA. Bone marrow mesenchymal stem cells suppress IL-9 in adjuvant-induced arthritis. Autoimmunity. 2018;51(1):25\u201334.","journal-title":"Autoimmunity"},{"issue":"12","key":"4495_CR161","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1080\/09603123.2022.2093841","volume":"33","author":"Y Buzda\u011fl\u0131","year":"2023","unstructured":"Buzda\u011fl\u0131 Y, et al. Effects of hesperidin on anti-inflammatory and antioxidant response in healthy people: a meta-analysis and meta-regression. Int J Environ Health Res. 2023;33(12):1390\u2013405.","journal-title":"Int J Environ Health Res"},{"issue":"3","key":"4495_CR162","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1002\/med.21762","volume":"41","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, et al. Tripterygium wilfordii: an inspiring resource for rheumatoid arthritis treatment. Med Res Rev. 2021;41(3):1337\u201374.","journal-title":"Med Res Rev"},{"key":"4495_CR163","doi-asserted-by":"crossref","unstructured":"Zhang L, Wei W. Anti-inflammatory and immunoregulatory effects of Paeoniflorin and total glucosides of Paeony. Volume 207. Pharmacology & Therapeutics; 2020. p. 107452.","DOI":"10.1016\/j.pharmthera.2019.107452"},{"key":"4495_CR164","doi-asserted-by":"publisher","first-page":"117657","DOI":"10.1016\/j.carbpol.2021.117657","volume":"258","author":"Z-Z Shang","year":"2021","unstructured":"Shang Z-Z, et al. Dendrobium huoshanense stem polysaccharide ameliorates rheumatoid arthritis in mice via Inhibition of inflammatory signaling pathways. Carbohydr Polym. 2021;258:117657.","journal-title":"Carbohydr Polym"},{"key":"4495_CR165","doi-asserted-by":"publisher","first-page":"945129","DOI":"10.3389\/fimmu.2022.945129","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu X, et al. Natural medicines of targeted rheumatoid arthritis and its action mechanism. Front Immunol. 2022;13:945129.","journal-title":"Front Immunol"},{"issue":"28","key":"4495_CR166","doi-asserted-by":"publisher","first-page":"e21222","DOI":"10.1097\/MD.0000000000021222","volume":"99","author":"T Qi","year":"2020","unstructured":"Qi T, et al. Cervus and cucumis peptides combined umbilical cord mesenchymal stem cells therapy for rheumatoid arthritis. Medicine. 2020;99(28):e21222.","journal-title":"Medicine"},{"issue":"4","key":"4495_CR167","doi-asserted-by":"publisher","first-page":"468","DOI":"10.2174\/1871530323666230223143011","volume":"24","author":"RH Ahmed","year":"2024","unstructured":"Ahmed RH, et al. Mesenchymal stem cells and Curcumin effectively mitigate freund\u2019s Adjuvant- induced arthritis via their Anti-inflammatory and gene expression of COX-1, IL-6 and IL-4. Endocr Metab Immune Disord Drug Targets. 2024;24(4):468\u201388.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"4495_CR168","doi-asserted-by":"publisher","first-page":"p3516834","DOI":"10.1155\/2021\/3516834","volume":"2021","author":"RH Ahmed","year":"2021","unstructured":"Ahmed RH, et al. Curcumin and mesenchymal stem cells ameliorate ankle, testis, and ovary deleterious histological changes in arthritic rats via suppression of oxidative stress and inflammation. Stem Cells Int. 2021;2021:p3516834.","journal-title":"Stem Cells Int"},{"issue":"4","key":"4495_CR169","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel G, D\u2019Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213\u201328.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4495_CR170","doi-asserted-by":"crossref","unstructured":"Zhang B et al. Therapeutic efficacy of mesenchymal stem\/stromal cell small extracellular vesicles in alleviating arthritic progression by restoring macrophage balance. Biomolecules, 2023. 13(10).","DOI":"10.3390\/biom13101501"},{"key":"4495_CR171","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.molimm.2021.04.001","volume":"135","author":"K Xu","year":"2021","unstructured":"Xu K, et al. Human umbilical cord mesenchymal stem cell-derived small extracellular vesicles ameliorate collagen-induced arthritis via Immunomodulatory T lymphocytes. Mol Immunol. 2021;135:36\u201344.","journal-title":"Mol Immunol"},{"issue":"5","key":"4495_CR172","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.7150\/thno.21072","volume":"8","author":"S Cosenza","year":"2018","unstructured":"Cosenza S, et al. Mesenchymal stem cells-derived exosomes are more immunosuppressive than microparticles in inflammatory arthritis. Theranostics. 2018;8(5):1399\u2013410.","journal-title":"Theranostics"},{"key":"4495_CR173","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fvets.2017.00039","volume":"4","author":"JG Casado","year":"2017","unstructured":"Casado JG, et al. Mesenchymal stem Cell-Derived exosomes: Immunomodulatory evaluation in an Antigen-Induced synovitis Porcine model. Front Veterinary Sci. 2017;4:39.","journal-title":"Front Veterinary Sci"},{"issue":"3","key":"4495_CR174","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/jcmm.17086","volume":"26","author":"X Tian","year":"2022","unstructured":"Tian X, et al. Gingival mesenchymal stem cell-derived exosomes are immunosuppressive in preventing collagen-induced arthritis. J Cell Mol Med. 2022;26(3):693\u2013708.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"4495_CR175","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s13075-023-03185-6","volume":"25","author":"S Bruckner","year":"2023","unstructured":"Bruckner S, et al. The therapeutic effects of gingival mesenchymal stem cells and their exosomes in a chimeric model of rheumatoid arthritis. Arthritis Res Therapy. 2023;25(1):211.","journal-title":"Arthritis Res Therapy"},{"key":"4495_CR176","doi-asserted-by":"crossref","unstructured":"Chen J et al. miRNA-148a-containing GMSC-derived EVs modulate Treg\/Th17 balance via IKKB\/NF-\u03baB pathway and treat a rheumatoid arthritis model. JCI Insight, 2024. 9(10).","DOI":"10.1172\/jci.insight.177841"},{"issue":"1","key":"4495_CR177","first-page":"132","volume":"22","author":"W Ma","year":"2022","unstructured":"Ma W, et al. miR-205-5p in exosomes divided from chondrogenic mesenchymal stem cells alleviated rheumatoid arthritis via regulating MDM2 in fibroblast-like synoviocytes. J Musculoskel Neuronal Interact. 2022;22(1):132\u201341.","journal-title":"J Musculoskel Neuronal Interact"},{"key":"4495_CR178","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.molimm.2022.01.002","volume":"143","author":"Y Huang","year":"2022","unstructured":"Huang Y, et al. miR-223 in exosomes from bone marrow mesenchymal stem cells ameliorates rheumatoid arthritis via downregulation of NLRP3 expression in macrophages. Mol Immunol. 2022;143:68\u201376.","journal-title":"Mol Immunol"},{"key":"4495_CR179","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3389\/fphys.2020.00441","volume":"11","author":"Q Meng","year":"2020","unstructured":"Meng Q, Qiu B. Exosomal MicroRNA-320a derived from mesenchymal stem cells regulates rheumatoid arthritis Fibroblast-Like synoviocyte activation by suppressing CXCL9 expression. Front Physiol. 2020;11:441.","journal-title":"Front Physiol"},{"issue":"1","key":"4495_CR180","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1159\/000534830","volume":"15","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Jiao Z, Wang S. Bone marrow mesenchymal stem cells release miR-378a-5p-Carried extracellular vesicles to alleviate rheumatoid arthritis. J Innate Immun. 2023;15(1):893\u2013910.","journal-title":"J Innate Immun"},{"key":"4495_CR181","doi-asserted-by":"publisher","first-page":"111365","DOI":"10.1016\/j.intimp.2023.111365","volume":"127","author":"L Mi","year":"2024","unstructured":"Mi L, et al. Human umbilical cord mesenchymal stem cell-derived exosomes loaded miR-451a targets ATF2 to improve rheumatoid arthritis. Int Immunopharmacol. 2024;127:111365.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"4495_CR182","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12891-020-3159-y","volume":"21","author":"H-Y Meng","year":"2020","unstructured":"Meng H-Y, Chen L-Q, Chen L-H. The Inhibition by human MSCs-derived miRNA-124a overexpression exosomes in the proliferation and migration of rheumatoid arthritis-related fibroblast-like synoviocyte cell. BMC Musculoskelet Disord. 2020;21(1):150.","journal-title":"BMC Musculoskelet Disord"},{"issue":"4","key":"4495_CR183","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2174\/1566523220666200916120708","volume":"20","author":"F Tavasolian","year":"2020","unstructured":"Tavasolian F, et al. miRNA-146a improves Immunomodulatory effects of MSC-derived exosomes in rheumatoid arthritis. Curr Gene Ther. 2020;20(4):297\u2013312.","journal-title":"Curr Gene Ther"},{"issue":"8","key":"4495_CR184","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.4049\/jimmunol.1800304","volume":"201","author":"Z Chen","year":"2018","unstructured":"Chen Z, et al. Therapeutic potential of mesenchymal Cell-Derived miRNA-150-5p-Expressing exosomes in rheumatoid arthritis mediated by the modulation of MMP14 and VEGF. J Immunol (Baltimore Md: 1950). 2018;201(8):2472\u201382.","journal-title":"J Immunol (Baltimore Md: 1950)"},{"issue":"6","key":"4495_CR185","doi-asserted-by":"publisher","first-page":"14545","DOI":"10.1080\/21655979.2022.2090379","volume":"13","author":"W Xu","year":"2022","unstructured":"Xu W, et al. Exosomes derived from fibrinogen-like protein 1-overexpressing bone marrow-derived mesenchymal stem cells ameliorates rheumatoid arthritis. Bioengineered. 2022;13(6):14545\u201361.","journal-title":"Bioengineered"},{"key":"4495_CR186","doi-asserted-by":"crossref","unstructured":"Kay AG et al. Therapeutic effects of hypoxic and Pro-Inflammatory priming of mesenchymal stem Cell-Derived extracellular vesicles in inflammatory arthritis. Int J Mol Sci, 2021. 23(1).","DOI":"10.3390\/ijms23010126"},{"issue":"12","key":"4495_CR187","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/stcltm\/szad065","volume":"12","author":"D Tsiapalis","year":"2023","unstructured":"Tsiapalis D, et al. Therapeutic effects of mesenchymal\/stromal stem cells and their derived extracellular vesicles in rheumatoid arthritis. Stem Cells Translational Med. 2023;12(12):849\u201362.","journal-title":"Stem Cells Translational Med"},{"issue":"1","key":"4495_CR188","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s13287-023-03523-0","volume":"14","author":"EW Choi","year":"2023","unstructured":"Choi EW, et al. Exosomes derived from mesenchymal stem cells primed with disease-condition-serum improved therapeutic efficacy in a mouse rheumatoid arthritis model via enhanced TGF-\u03b21 production. Stem Cell Res Ther. 2023;14(1):283.","journal-title":"Stem Cell Res Ther"},{"key":"4495_CR189","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fimmu.2019.00018","volume":"10","author":"JP Miranda","year":"2019","unstructured":"Miranda JP, et al. The secretome derived from 3D-Cultured umbilical cord tissue MSCs counteracts manifestations typifying rheumatoid arthritis. Front Immunol. 2019;10:18.","journal-title":"Front Immunol"},{"issue":"1","key":"4495_CR190","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12010-022-04090-5","volume":"195","author":"X He","year":"2023","unstructured":"He X, et al. Curcumin-Loaded mesenchymal stem Cell-Derived exosomes efficiently attenuate proliferation and inflammatory response in rheumatoid arthritis Fibroblast-Like synoviocytes. Appl Biochem Biotechnol. 2023;195(1):51\u201367.","journal-title":"Appl Biochem Biotechnol"},{"key":"4495_CR191","doi-asserted-by":"crossref","unstructured":"You DG et al. Metabolically engineered stem cell-derived exosomes to regulate macrophage heterogeneity in rheumatoid arthritis. Sci Adv, 2021. 7(23).","DOI":"10.1126\/sciadv.abe0083"},{"issue":"1","key":"4495_CR192","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12951-023-01865-8","volume":"21","author":"K Rui","year":"2023","unstructured":"Rui K, et al. Exosome inspired photo-triggered gelation hydrogel composite on modulating immune pathogenesis for treating rheumatoid arthritis. J Nanobiotechnol. 2023;21(1):111.","journal-title":"J Nanobiotechnol"},{"key":"4495_CR193","doi-asserted-by":"crossref","unstructured":"Yin JQ, Zhu J, Ankrum JA. Manufacturing of primed mesenchymal stromal cells for therapy. Nat Biomedical Eng, 2019. 3(2).","DOI":"10.1038\/s41551-018-0325-8"},{"issue":"1","key":"4495_CR194","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13045-021-01037-x","volume":"14","author":"T Zhou","year":"2021","unstructured":"Zhou T, et al. Challenges and advances in clinical applications of mesenchymal stromal cells. J Hematol Oncol. 2021;14(1):24.","journal-title":"J Hematol Oncol"},{"issue":"6","key":"4495_CR195","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41423-023-00983-5","volume":"20","author":"X Yang","year":"2023","unstructured":"Yang X, et al. Mesenchymal stromal cells in hepatic fibrosis\/cirrhosis: from pathogenesis to treatment. Cell Mol Immunol. 2023;20(6):583\u201399.","journal-title":"Cell Mol Immunol"},{"key":"4495_CR196","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fimmu.2012.00297","volume":"3","author":"E Eggenhofer","year":"2012","unstructured":"Eggenhofer E, et al. Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Front Immunol. 2012;3:297.","journal-title":"Front Immunol"},{"key":"4495_CR197","doi-asserted-by":"publisher","first-page":"22293","DOI":"10.1038\/srep22293","volume":"6","author":"H Wang","year":"2016","unstructured":"Wang H, et al. A physiologically based kinetic model for elucidating the in vivo distribution of administered mesenchymal stem cells. Sci Rep. 2016;6:22293.","journal-title":"Sci Rep"},{"key":"4495_CR198","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.2147\/DDDT.S374827","volume":"16","author":"C Liu","year":"2022","unstructured":"Liu C, et al. Dehydrozingerone alleviates hyperalgesia, oxidative stress and inflammatory factors in complete freund\u2019s Adjuvant-Induced arthritic rats. Drug Des Devel Ther. 2022;16:3015\u201322.","journal-title":"Drug Des Devel Ther"},{"issue":"12","key":"4495_CR199","doi-asserted-by":"publisher","first-page":"6423","DOI":"10.1007\/s12010-022-04091-4","volume":"194","author":"M Zhou","year":"2022","unstructured":"Zhou M, et al. Xanthorrhizol ameliorates oxidative stress and inflammation in freund\u2019s complete Adjuvant-Induced rheumatoid arthritis in rats. Appl Biochem Biotechnol. 2022;194(12):6423\u201337.","journal-title":"Appl Biochem Biotechnol"},{"issue":"9","key":"4495_CR200","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s12272-018-1089-0","volume":"42","author":"Y Li","year":"2019","unstructured":"Li Y, et al. Ligustrazine attenuates inflammation and oxidative stress in a rat model of arthritis via the Sirt1\/NF-\u03baB and Nrf-2\/HO-1 pathways. Arch Pharm Res. 2019;42(9):824\u201331.","journal-title":"Arch Pharm Res"},{"issue":"9624","key":"4495_CR201","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","volume":"371","author":"K Le Blanc","year":"2008","unstructured":"Le Blanc K, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet (London England). 2008;371(9624):1579\u201386.","journal-title":"Lancet (London England)"},{"issue":"1","key":"4495_CR202","doi-asserted-by":"publisher","first-page":"e1009","DOI":"10.1038\/cddis.2013.537","volume":"5","author":"X Chen","year":"2014","unstructured":"Chen X, et al. The interaction between mesenchymal stem cells and steroids during inflammation. Cell Death Dis. 2014;5(1):e1009.","journal-title":"Cell Death Dis"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04495-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04495-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04495-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T13:51:09Z","timestamp":1757253069000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04495-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":202,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4495"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04495-z","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"379"}}